• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过将一种骨祖细胞亚型负载于脱细胞骨基质粉末上构建可注射骨形成单元用于骨再生

Constructing Injectable Bone-Forming Units by Loading a Subtype of Osteoprogenitors on Decellularized Bone Matrix Powders for Bone Regeneration.

作者信息

Xu Yan, Yan Shaohang, Chen Can, Lu Bangbao, Zhao Ruibo

机构信息

Department of Sports Medicine, Xiangya Hospital, Central South University, Changsha, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Cell Dev Biol. 2022 Jul 6;10:910819. doi: 10.3389/fcell.2022.910819. eCollection 2022.

DOI:10.3389/fcell.2022.910819
PMID:35874802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9298785/
Abstract

Bone defects resulting from trauma or tumor are one of the most challenging problems in clinical settings. Current tissue engineering (TE) strategies for managing bone defects are insufficient, owing to without using optimal osteoconductive material and seeding cells capable of superior osteogenic potential; thus their efficacy is instable. Herein, a novel TE strategy was developed for treating bone defects. First, the decellularized bone matrix (DBM) was manufactured into powders, and these DBM powders preserved the ultrastructural and compositional properties of native trabecular bone, are non-cytotoxic and low-immunogenic, and are capable of inducing the interacted stem cells differentiating into osteogenic lineage. Then, a subtype of osteoprogenitors was isolated from mouse long bones, and its high osteogenic potential was identified . After that, we constructed a "bone-forming unit" by seeding the special subtype of osteoprogenitors onto the DBM powders. performance of the "bone-forming units" was determined by injecting into the defect site of a mouse femoral epiphysis bone defect model. The results indicated that the "bone-forming unit" was capable of enhancing bone defect healing by regulating new bone formation and remodeling. Overall, the study establishes a protocol to construct a novel "bone-forming unit," which may be an alternative strategy in future bone TE application.

摘要

由创伤或肿瘤导致的骨缺损是临床环境中最具挑战性的问题之一。由于未使用最佳的骨传导材料和具有卓越成骨潜能的种子细胞,当前用于治疗骨缺损的组织工程(TE)策略并不充分;因此其疗效不稳定。在此,我们开发了一种用于治疗骨缺损的新型TE策略。首先,将脱细胞骨基质(DBM)制成粉末,这些DBM粉末保留了天然小梁骨的超微结构和组成特性,无细胞毒性且免疫原性低,并且能够诱导相互作用的干细胞分化为成骨谱系。然后,从小鼠长骨中分离出一种骨祖细胞亚型,并鉴定了其高成骨潜能。之后,我们通过将这种特殊的骨祖细胞亚型接种到DBM粉末上构建了一个“骨形成单元”。通过将“骨形成单元”注入小鼠股骨骨骺骨缺损模型的缺损部位来测定其性能。结果表明,“骨形成单元”能够通过调节新骨形成和重塑来促进骨缺损愈合。总体而言,该研究建立了一种构建新型“骨形成单元”的方案,这可能是未来骨TE应用中的一种替代策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/86a6e6252fae/fcell-10-910819-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/c6c5c77b376f/fcell-10-910819-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/c6659430bad4/fcell-10-910819-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/617c96e57fb5/fcell-10-910819-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/68261b7fd84d/fcell-10-910819-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/ec8beb0a3c8d/fcell-10-910819-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/335cca31d759/fcell-10-910819-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/a548f15a9666/fcell-10-910819-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/3259f94351dd/fcell-10-910819-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/86a6e6252fae/fcell-10-910819-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/c6c5c77b376f/fcell-10-910819-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/c6659430bad4/fcell-10-910819-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/617c96e57fb5/fcell-10-910819-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/68261b7fd84d/fcell-10-910819-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/ec8beb0a3c8d/fcell-10-910819-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/335cca31d759/fcell-10-910819-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/a548f15a9666/fcell-10-910819-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/3259f94351dd/fcell-10-910819-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96c6/9298785/86a6e6252fae/fcell-10-910819-g009.jpg

相似文献

1
Constructing Injectable Bone-Forming Units by Loading a Subtype of Osteoprogenitors on Decellularized Bone Matrix Powders for Bone Regeneration.通过将一种骨祖细胞亚型负载于脱细胞骨基质粉末上构建可注射骨形成单元用于骨再生
Front Cell Dev Biol. 2022 Jul 6;10:910819. doi: 10.3389/fcell.2022.910819. eCollection 2022.
2
Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.用于治疗长骨骨不连的成骨蛋白-1:一项循证分析
Ont Health Technol Assess Ser. 2005;5(6):1-57. Epub 2005 Apr 1.
3
Large-sized bone defect repair by combining a decalcified bone matrix framework and bone regeneration units based on photo-crosslinkable osteogenic microgels.基于光交联成骨微凝胶的脱钙骨基质框架与骨再生单元联合修复大尺寸骨缺损
Bioact Mater. 2021 Dec 18;14:97-109. doi: 10.1016/j.bioactmat.2021.12.013. eCollection 2022 Aug.
4
Magneto-sensitive decellularized bone matrix with or without low frequency-pulsed electromagnetic field exposure for the healing of a critical-size bone defect.磁敏感去细胞骨基质联合或不联合低频脉冲电磁场治疗骨缺损
Mater Sci Eng C Mater Biol Appl. 2021 May;124:112065. doi: 10.1016/j.msec.2021.112065. Epub 2021 Mar 26.
5
Decellularized bone matrix/oleoyl chitosan derived supramolecular injectable hydrogel promotes efficient bone integration.脱细胞骨基质/油酰壳聚糖衍生的超分子可注射水凝胶促进高效骨整合。
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111604. doi: 10.1016/j.msec.2020.111604. Epub 2020 Oct 9.
6
New Bone Formation in the Whole Decellularized Cortical Bone Scaffold Using the Model of Revitalizing a Haversian System.使用激活哈弗系统模型在全脱细胞化皮质骨支架中实现新骨形成。
J Craniofac Surg. 2022 May 1;33(3):962-968. doi: 10.1097/SCS.0000000000008072. Epub 2021 Sep 10.
7
Poly (glycerol sebacate) elastomer supports bone regeneration by its mechanical properties being closer to osteoid tissue rather than to mature bone.聚(癸二酸丙二醇酯)弹性体通过其机械性能更接近类骨质组织而不是成熟骨,从而支持骨再生。
Acta Biomater. 2017 May;54:95-106. doi: 10.1016/j.actbio.2017.01.053. Epub 2017 Jan 19.
8
The osteogenetic efficacy of goat bone marrow-enriched self-assembly peptide/demineralized bone matrix in vitro and in vivo.富含山羊骨髓的自组装肽/脱矿骨基质在体内外的成骨效果。
Tissue Eng Part A. 2015 Apr;21(7-8):1398-408. doi: 10.1089/ten.TEA.2014.0294. Epub 2015 Feb 12.
9
The Treatment Efficacy of Bone Tissue Engineering Strategy for Repairing Segmental Bone Defects Under Osteoporotic Conditions.骨组织工程策略修复骨质疏松条件下节段性骨缺损的治疗效果
Tissue Eng Part A. 2015 Sep;21(17-18):2346-55. doi: 10.1089/ten.TEA.2015.0071. Epub 2015 Jul 31.
10
Enhancing the osteogenic efficacy of human bone marrow aspirate: concentrating osteoprogenitors using wave-assisted filtration.增强人骨髓抽吸物的成骨疗效:使用波辅助过滤浓缩成骨祖细胞。
Cytotherapy. 2013 Feb;15(2):242-52. doi: 10.1016/j.jcyt.2012.09.004. Epub 2012 Dec 12.

引用本文的文献

1
Effects of the matrix-bounded nanovesicles of high-hydrostatic pressure decellularized tissues on neural regeneration.高静水压脱细胞组织的基质包被纳米囊泡对神经再生的影响。
Sci Technol Adv Mater. 2024 Sep 18;25(1):2404380. doi: 10.1080/14686996.2024.2404380. eCollection 2024.
2
Three Birds, One Stone: An Osteo-Microenvironment Stage-Regulative Scaffold for Bone Defect Repair through Modulating Early Osteo-Immunomodulation, Middle Neovascularization, and Later Osteogenesis.一石三鸟:通过调节早期骨免疫调节、中期血管新生和后期成骨作用来修复骨缺损的一种骨微环境阶段调节支架。
Adv Sci (Weinh). 2024 Feb;11(6):e2306428. doi: 10.1002/advs.202306428. Epub 2023 Dec 7.

本文引用的文献

1
Strategies for large bone defect reconstruction after trauma, infections or tumour excision: a comprehensive review of the literature.创伤、感染或肿瘤切除后大骨缺损的重建策略:文献综述。
Eur J Med Res. 2021 Oct 2;26(1):118. doi: 10.1186/s40001-021-00593-9.
2
Effects of Therapy with Fibrin Glue combined with Mesenchymal Stem Cells (MSCs) on Bone Regeneration: A Systematic Review.纤维蛋白胶联合间充质干细胞治疗对骨再生的影响:系统评价。
Cells. 2021 Sep 5;10(9):2323. doi: 10.3390/cells10092323.
3
Recent advancements in decellularized matrix technology for bone tissue engineering.
脱细胞基质技术在骨组织工程中的最新进展。
Differentiation. 2021 Sep-Oct;121:25-34. doi: 10.1016/j.diff.2021.08.004. Epub 2021 Aug 23.
4
A bone regeneration strategy dual delivery of demineralized bone matrix powder and hypoxia-pretreated bone marrow stromal cells using an injectable self-healing hydrogel.一种骨再生策略——使用可注射自修复水凝胶双重递送脱矿骨基质粉末和缺氧预处理的骨髓基质细胞。
J Mater Chem B. 2021 Jan 21;9(2):479-493. doi: 10.1039/d0tb01924k.
5
Poly(lactic--glycolic acid)-based composite bone-substitute materials.聚乳酸-乙醇酸共聚物基复合骨替代材料
Bioact Mater. 2020 Aug 29;6(2):346-360. doi: 10.1016/j.bioactmat.2020.08.016. eCollection 2021 Feb.
6
Acellular polycaprolactone scaffolds laden with fibroblast/endothelial cell-derived extracellular matrix for bone regeneration.细胞外基质负载纤维母细胞/内皮细胞衍生细胞外基质的去细胞聚己内酯支架用于骨再生。
J Biomed Mater Res A. 2020 Feb;108(2):351-364. doi: 10.1002/jbm.a.36821. Epub 2019 Oct 24.
7
Stem Cells for Bone Regeneration: Current State and Future Directions.用于骨再生的干细胞:现状与未来方向
J Craniofac Surg. 2019 May/Jun;30(3):730-735. doi: 10.1097/SCS.0000000000005250.
8
Book-Shaped Acellular Fibrocartilage Scaffold with Cell-loading Capability and Chondrogenic Inducibility for Tissue-Engineered Fibrocartilage and Bone-Tendon Healing.具有细胞加载能力和软骨诱导能力的书型去细胞纤维软骨支架,用于组织工程纤维软骨和骨腱愈合。
ACS Appl Mater Interfaces. 2019 Jan 23;11(3):2891-2907. doi: 10.1021/acsami.8b20563. Epub 2019 Jan 8.
9
Biomimetic Scaffolds for Bone Tissue Engineering.仿生支架在骨组织工程中的应用
Adv Exp Med Biol. 2018;1064:109-121. doi: 10.1007/978-981-13-0445-3_7.
10
Identification of the Human Skeletal Stem Cell.人成体干细胞的鉴定
Cell. 2018 Sep 20;175(1):43-56.e21. doi: 10.1016/j.cell.2018.07.029.